anti-PD-L1 antibody
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for anti-PD-L1 antibody, covering 2025-04-09 to 2026-02-06. Get the full timeline:
Most recent: Clinical Trial Update: Niraparib Added to Anti-PD-L1 Antibody Maintenance in SLFN11-positive, Extensive-disease SCLC [Phase 2]